Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8624949 | Bone | 2018 | 6 Pages |
Abstract
Based on CTFEA, 39% of the patients with femoral MBD who were referred and underwent prophylactic stabilization may not have needed surgery. These results indicate that a prospective randomized clinical trial evaluating CTFEA as a criterion for determining the need for surgical stabilization in patients with MBD of the femur may be warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Amir Sternheim, Ornit Giladi, Yair Gortzak, Michael Drexler, Moshe Salai, Nir Trabelsi, Charles Milgrom, Zohar Yosibash,